Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Nuclear medicine program progress report for quarter ending March 31, 1995

Technical Report ·
DOI:https://doi.org/10.2172/81009· OSTI ID:81009
In this report the conditions for ``direct`` labeling of the anti-granulocyte (MAb) BW 250/183 monoclonal antibody with rhenium-188 (Re-188) from a generator are described. Re-188-BW 250/183 is of interest for potential use for bone marrow ablation. The labeling time, temperature, pH, and the amount of tin and citric acid were optimized utilizing IgG. Radiolabeling yields of greater than 97% were achieved using 1 mL of a phthalate/tartrate buffer (pH 5.{und M}=?), 250 {micro} g BW 250/183, 1.0 mg citric acid, 400 {micro} g tin (II) chloride, and 1 mL of the tungsten-188/rhenium-188 generator eluent (200--800 {micro} Ci of Re-188). Analysis of the Re-188-labeled IgG and BW 250/183 was performed by Instant Thin Layer Chromatography (ITLC), Sephadex purification and High Performance Liquid Chromatography (HPLC). When the labeling was performed at room temperature or 37 C, in vitro stability studies performed in HSA solution, cysteine solution, 6 {und M} urea solution and a 1% casein solution showed that the Re-188 label demonstrated a similar stability profile in all solutions. Initial studies indicate that Re-188-BW 250/183 retained {approximately} 90% of immunoreactivity when compared to the technetium-99m labeled antibody prepared from the same kit. During this period, several radioisotopes prepared in the ORNL HFIR were also supplied on a cost-recovery basis or provided to collaborators for ongoing collaborative projects. These include tin-117m, processed tungsten-188 and the ORNL alumina-based tungsten-188/rhenium-188 generators.
Research Organization:
Oak Ridge National Lab., TN (United States)
Sponsoring Organization:
USDOE, Washington, DC (United States)
DOE Contract Number:
AC05-84OR21400
OSTI ID:
81009
Report Number(s):
ORNL/TM--12965; ON: DE95013506
Country of Publication:
United States
Language:
English

Similar Records

Nuclear Medicine Program progress report for quarter ending September 30, 1990
Technical Report · Thu Jan 31 23:00:00 EST 1991 · OSTI ID:6228890

Use of tin-117m to study the role of tin in the direct labeling of proteins with rhenium-188
Journal Article · Wed May 01 00:00:00 EDT 1996 · Journal of Nuclear Medicine · OSTI ID:447778

Rhenium labeled peptides and antibodies for cancer therapy. CRADA final report
Technical Report · Mon Aug 12 00:00:00 EDT 1996 · OSTI ID:10116006